Celeste Laureyssen, Fahri Küçükali, Jasper Van Dongen, Klara Gawor, Sandra O. Tomé, Alicja Ronisz, Markus Otto, Christine A. F. von Arnim, Philip Van Damme, Rik Vandenberghe, Dietmar Rudolf Thal, Kristel Sleegers
{"title":"基于假设的已知阿尔茨海默病风险变异调查揭示了阿尔茨海默型痴呆症神经病理学病变的遗传基础","authors":"Celeste Laureyssen, Fahri Küçükali, Jasper Van Dongen, Klara Gawor, Sandra O. Tomé, Alicja Ronisz, Markus Otto, Christine A. F. von Arnim, Philip Van Damme, Rik Vandenberghe, Dietmar Rudolf Thal, Kristel Sleegers","doi":"10.1007/s00401-024-02815-w","DOIUrl":null,"url":null,"abstract":"<div><p>Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Besides neurofibrillary tangles and amyloid beta (A<i>β</i>) plaques, a wide range of co-morbid neuropathological features can be observed in AD brains. Since AD has a very strong genetic background and displays a wide phenotypic heterogeneity, this study aims at investigating the genetic underpinnings of co-morbid and hallmark neuropathological lesions. This was realized by obtaining the genotypes for 75 AD risk variants from low-coverage whole-genome sequencing data for 325 individuals from the Leuven Brain Collection. Association testing with deeply characterized neuropathological lesions revealed a strong and likely direct effect of rs117618017, a SNP in exon 1 of <i>APH1B</i>, with tau-related pathology. Second, a relation between <i>APOE</i> and granulovacuolar degeneration, a proxy for necroptosis, was also discovered in addition to replication of the well-known association of <i>APOE</i> with AD hallmark neuropathological lesions. Additionally, several nominal associations with AD risk genes were detected for pTDP pathology, <i>α</i>-synuclein lesions and pTau-related pathology. These findings were confirmed in a meta-analysis with three independent cohorts. For example, we replicated a prior association between <i>TPCN1</i> (rs6489896) and LATE-NC risk. Furthermore, we identified new putative LATE-NC-linked SNPs, including rs7068231, located upstream of <i>ANK3</i>. We found association between <i>BIN1</i> (rs6733839) and α-synuclein pathology, and replicated a prior association between <i>USP6NL</i> (rs7912495) and Lewy body pathology. Additionally, we also found that <i>UMAD1</i> (rs6943429) was nominally associated with Lewy body pathology. Overall, these results contribute to a broader general understanding of how AD risk variants discovered in large-scale clinical genome-wide association studies are involved in the pathological mechanisms of AD and indicate the importance of downstream elimination of phenotypic heterogeneity introduced in these studies.</p></div>","PeriodicalId":7012,"journal":{"name":"Acta Neuropathologica","volume":"148 1","pages":""},"PeriodicalIF":9.3000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00401-024-02815-w.pdf","citationCount":"0","resultStr":"{\"title\":\"Hypothesis-based investigation of known AD risk variants reveals the genetic underpinnings of neuropathological lesions observed in Alzheimer’s-type dementia\",\"authors\":\"Celeste Laureyssen, Fahri Küçükali, Jasper Van Dongen, Klara Gawor, Sandra O. Tomé, Alicja Ronisz, Markus Otto, Christine A. F. von Arnim, Philip Van Damme, Rik Vandenberghe, Dietmar Rudolf Thal, Kristel Sleegers\",\"doi\":\"10.1007/s00401-024-02815-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Besides neurofibrillary tangles and amyloid beta (A<i>β</i>) plaques, a wide range of co-morbid neuropathological features can be observed in AD brains. Since AD has a very strong genetic background and displays a wide phenotypic heterogeneity, this study aims at investigating the genetic underpinnings of co-morbid and hallmark neuropathological lesions. This was realized by obtaining the genotypes for 75 AD risk variants from low-coverage whole-genome sequencing data for 325 individuals from the Leuven Brain Collection. Association testing with deeply characterized neuropathological lesions revealed a strong and likely direct effect of rs117618017, a SNP in exon 1 of <i>APH1B</i>, with tau-related pathology. Second, a relation between <i>APOE</i> and granulovacuolar degeneration, a proxy for necroptosis, was also discovered in addition to replication of the well-known association of <i>APOE</i> with AD hallmark neuropathological lesions. Additionally, several nominal associations with AD risk genes were detected for pTDP pathology, <i>α</i>-synuclein lesions and pTau-related pathology. These findings were confirmed in a meta-analysis with three independent cohorts. For example, we replicated a prior association between <i>TPCN1</i> (rs6489896) and LATE-NC risk. Furthermore, we identified new putative LATE-NC-linked SNPs, including rs7068231, located upstream of <i>ANK3</i>. We found association between <i>BIN1</i> (rs6733839) and α-synuclein pathology, and replicated a prior association between <i>USP6NL</i> (rs7912495) and Lewy body pathology. Additionally, we also found that <i>UMAD1</i> (rs6943429) was nominally associated with Lewy body pathology. Overall, these results contribute to a broader general understanding of how AD risk variants discovered in large-scale clinical genome-wide association studies are involved in the pathological mechanisms of AD and indicate the importance of downstream elimination of phenotypic heterogeneity introduced in these studies.</p></div>\",\"PeriodicalId\":7012,\"journal\":{\"name\":\"Acta Neuropathologica\",\"volume\":\"148 1\",\"pages\":\"\"},\"PeriodicalIF\":9.3000,\"publicationDate\":\"2024-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://link.springer.com/content/pdf/10.1007/s00401-024-02815-w.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Neuropathologica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00401-024-02815-w\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Neuropathologica","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00401-024-02815-w","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
阿尔茨海默病(AD)是全球痴呆症的主要病因。除了神经纤维缠结和淀粉样β(Aβ)斑块外,在阿尔茨海默病大脑中还可观察到多种共病神经病理学特征。由于注意力缺失症具有很强的遗传背景,并表现出广泛的表型异质性,本研究旨在调查共病和标志性神经病理学病变的遗传基础。为此,研究人员从鲁汶脑库 325 个个体的低覆盖率全基因组测序数据中获得了 75 个老年痴呆症风险变体的基因型。与深度神经病理学病变的关联测试表明,APH1B 第 1 外显子中的 SNP rs117618017 与 tau 相关病理有很强的直接影响。其次,APOE 与粒细胞变性(代表坏死)之间的关系也被发现,此外,众所周知的 APOE 与 AD 标志性神经病理学病变之间的关系也被证实。此外,在 pTDP 病理学、α-突触核蛋白病变和 pTau 相关病理学方面,还发现了一些与 AD 风险基因的名义关联。这些发现在三组独立队列的荟萃分析中得到了证实。例如,我们重复了之前发现的 TPCN1(rs6489896)与 LATE-NC 风险之间的关联。此外,我们还发现了新的可能与 LATE-NC 相关的 SNPs,包括位于 ANK3 上游的 rs7068231。我们发现了 BIN1(rs6733839)与α-突触核蛋白病理学之间的关联,并复制了之前 USP6NL(rs7912495)与路易体病理学之间的关联。此外,我们还发现 UMAD1(rs6943429)与路易体病理学有名义上的关联。总之,这些结果有助于人们更广泛地了解在大规模临床全基因组关联研究中发现的AD风险变体是如何参与AD病理机制的,并表明了从下游消除这些研究中引入的表型异质性的重要性。
Hypothesis-based investigation of known AD risk variants reveals the genetic underpinnings of neuropathological lesions observed in Alzheimer’s-type dementia
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Besides neurofibrillary tangles and amyloid beta (Aβ) plaques, a wide range of co-morbid neuropathological features can be observed in AD brains. Since AD has a very strong genetic background and displays a wide phenotypic heterogeneity, this study aims at investigating the genetic underpinnings of co-morbid and hallmark neuropathological lesions. This was realized by obtaining the genotypes for 75 AD risk variants from low-coverage whole-genome sequencing data for 325 individuals from the Leuven Brain Collection. Association testing with deeply characterized neuropathological lesions revealed a strong and likely direct effect of rs117618017, a SNP in exon 1 of APH1B, with tau-related pathology. Second, a relation between APOE and granulovacuolar degeneration, a proxy for necroptosis, was also discovered in addition to replication of the well-known association of APOE with AD hallmark neuropathological lesions. Additionally, several nominal associations with AD risk genes were detected for pTDP pathology, α-synuclein lesions and pTau-related pathology. These findings were confirmed in a meta-analysis with three independent cohorts. For example, we replicated a prior association between TPCN1 (rs6489896) and LATE-NC risk. Furthermore, we identified new putative LATE-NC-linked SNPs, including rs7068231, located upstream of ANK3. We found association between BIN1 (rs6733839) and α-synuclein pathology, and replicated a prior association between USP6NL (rs7912495) and Lewy body pathology. Additionally, we also found that UMAD1 (rs6943429) was nominally associated with Lewy body pathology. Overall, these results contribute to a broader general understanding of how AD risk variants discovered in large-scale clinical genome-wide association studies are involved in the pathological mechanisms of AD and indicate the importance of downstream elimination of phenotypic heterogeneity introduced in these studies.
期刊介绍:
Acta Neuropathologica publishes top-quality papers on the pathology of neurological diseases and experimental studies on molecular and cellular mechanisms using in vitro and in vivo models, ideally validated by analysis of human tissues. The journal accepts Original Papers, Review Articles, Case Reports, and Scientific Correspondence (Letters). Manuscripts must adhere to ethical standards, including review by appropriate ethics committees for human studies and compliance with principles of laboratory animal care for animal experiments. Failure to comply may result in rejection of the manuscript, and authors are responsible for ensuring accuracy and adherence to these requirements.